ETV6-ABL1-positive "chronic myeloid leukemia": clinical and molecular response to tyrosine kinase inhibition. Article uri icon

Overview

publication date

  • December 29, 2010

Research

keywords

  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Oncogene Proteins, Fusion
  • Piperazines
  • Protein Kinase Inhibitors
  • Protein-Tyrosine Kinases
  • Pyrimidines

Identity

PubMed Central ID

  • PMC3031707

Scopus Document Identifier

  • 79551639093

Digital Object Identifier (DOI)

  • 10.3324/haematol.2010.036673

PubMed ID

  • 21193423

Additional Document Info

volume

  • 96

issue

  • 2